Contraceptive Drugs Market to Grow at a CAGR of 7.7% over 2023-2030; Increase in Initiatives to Raise Awareness of Contraception by Healthcare Organizations to Boost Market Growth

The global contraceptive drugs market size was valued at USD 17.50 billion in 2022. The market is projected to grow from USD 18.57 billion in 2023 to USD 31.30 billion by 2030, exhibiting a CAGR of 7.7% during the forecast period. Rising concerns about the rapid growth in population are resulting in a greater focus on educating the general public about various contraception methods, which are accessible. The key element driving the market expansion is the growing emphasis on raising awareness of contraception options by top market participants and healthcare organizations.

Fortune Business Insights™ presents this information in its report titled, “Contraceptive Drugs Market Size, Share & COVID-19 Impact Analysis, By Product (Oral (Combined Contraceptives and Progestin-only Pills), Injectable, and Patches), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels & NGOs, and Others), and Regional Forecast, 2023-2030”.

Decreased Demand for Contraceptive Drugs during Pandemic Hampered Market Growth

The COVID-19 pandemic hindered the demand for contraceptives globally, restraining the market growth. Due to the COVID-19 pandemic's consequences, most of the major participants saw a notable drop in their revenues from the sales of contraceptive drugs. For instance, Bayer AG reported a revenue of USD 797.6 million from the sales of YAZ hormonal contraceptive pills in 2020, compared to the sales of USD 810.7 million in 2019, which is a decrease of 1.6% from 2019-2020.

Agile Therapeutics, Inc. Concentrates on Collaborations to Increase its Product Availability

In January 2022, to expand the accessibility of Twirla, an efficient patch, in the U.S., Agile Therapeutics, Inc. collaborated with Afaxys Pharma, LLC. Such collaborations are pushing emerging market players to implement innovative techniques to produce effective contraceptive drugs. This way, market participants are gaining a strong foothold in the industry, boosting market expansion.

Rising Focus on Enhancing Women's Sexual and Reproductive Wellness is Propelling Market Growth

The contraceptive drugs market share is expected to grow significantly during the forecast period. Through various campaigns and public awareness initiatives, non-profit organizations and local and national healthcare organizations are increasingly focusing on enhancing women's sexual and reproductive wellness. These for-profit and nonprofit organizations support contraceptive methods and raise public knowledge of them, especially the rising use of these drugs.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/contraceptive-drugs-market-100063

Increased Emphasis on Strategic Alliances by Key Market Players to Augment Market Growth

A few international companies and several local generic drug producers comprise the fragmented global market. To stand out from the competition and get a competitive edge, the leading industry participants concentrate on building strategic alliances.

Notable Industry Development

• February 2021 – The U.S. FDA granted Amneal Pharmaceuticals, Inc. approval for its Abbreviated New Drug Application for Zafemy, the generic form of Ortho Evra, which helps women avoid getting pregnant.

List of the Companies Profiled in the Report:

• Piramal Enterprises Ltd. (India)


• Agile Therapeutics (U.S.)


• Johnson & Johnson Services, Inc. (U.S.)


• AbbVie Inc. (U.S.)


• Pfizer Inc. (U.S.)


• Teva Pharmaceutical Industries Ltd. (Israel)


• Viatris Inc. (U.S.)


• Amneal Pharmaceuticals, Inc. (U.S.)


• Bayer AG (Germany)

Further Report Findings-

• North America held the highest market share in 2022. The market in the region is expanding as a result of the high level of awareness regarding birth control pills among the population.


• Europe has the second-largest market share globally due to the presence of an enhanced healthcare system.


• Latin America and the Middle East & Africa are expected to witness significant growth during the forecast period. Surging initiatives by the government and other organization to raise knowledge about contraceptive drugs led to the rapid adoption of contraceptives among women, which is boosting market expansion in  


• The oral segment holds the largest market share due to the growing usage of oral drugs in developed and developing countries globally.


• In 2022, the retail pharmacy segment commanded the global market. This prominence of the retail pharmacy category can be linked to the rising demand for Over-the-Counter (OTC) contraception medications among the general public and greater awareness regarding various contraceptive options.

Table of Segmentation